TLSA 6-K: SEC filing
Tiziana Life Sciences
Filed with the SEC on · accession 0001213900-26-117181
TLSA filed a 6-K (foreign company report) with the SEC on Nov 9, 2026. How foreign companies listed in the US report news and events — like an 8-K for them.
Summary of the filing
Tiziana Life Sciences announced it will present at BIO-Europe 2026 and is hosting a conference call and webcast with Key Opinion Leaders to discuss positive topline results from the Phase 2a INFORM-MS trial of intranasal foralumab in non-active secondary progressive multiple sclerosis (na-SPMS).
Key details
✦ Ask GOAX AI about this filing — what it means for TLSA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TLSA?
Click hereFrequently asked questions
What did TLSA file with the SEC on Nov 9, 2026?
TLSA filed a 6-K (SEC filing). Tiziana Life Sciences announced it will present at BIO-Europe 2026 and is hosting a conference call and webcast with Key Opinion Leaders to discuss positive topline results from the Phase 2a INFORM-MS trial of intranasal foralumab in non-active secondary progressive multiple sclerosis (na-SPMS).
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Other TLSA SEC filings
Get alerts when TLSA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days